This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Decker, M. Articles by Stern, R. Search for Related Content PubMed PubMed Citation Articles by Decker, M. Articles by Stern, R.

Hyaluronic Acid-stimulating Activity in Sera from the Bovine Fetus and from Breast Cancer Patients¹

Departments of Pathology [M. D., E. S. C., A. M., J. H., R. S.], and Surgery [M. T. L.], School of Medicine, University of California, San Francisco, California 94143; Peralta Cancer Research Institute, Oakland, California [C. D.]; and Hyclone Laboratories [R. Sp.], Logan, Utah 84321

The sine qua non of malignancy is the ability of tumor cells to migrate and invade surrounding tissue. There are many substances that have been described that enhance cell motility and hyaluronic acid is prominent among these. Hyaluronic acid is a high molecular weight alternating disaccharide polymer found in abundance in extracellular matrices whenever rapid cell proliferation or tissue regeneration and repair occur. It creates a permissive environment for cell motility during embryogenesis, and high levels of hyaluronic acid also correlate with increased tumor cell invasion and aggressiveness. Little is known about the regulation of hyaluronic acid production, either in normal tissue or in malignancy. In this study, we characterize a hyaluronic acid-stimulating activity in fetal calf serum and describe a similar activity in the sera of breast cancer patients. The stimulating activity was measured by placing aliquots of test substance on fibrosarcoma cells. These indicator cells, which synthesize copious quantities of hyaluronic acid, respond to stimulation in a time- and dose-dependent fashion. The fetal calf serum hyaluronic acid-stimulating activity is maximum early in gestation and then falls rapidly to essentially no activity at term. This activity was partially purified from 120-day fetal calf serum by concanavalin A-Sepharose affinity and ion exchange chromatography and is accounted for by a glycoprotein with a molecular weight of 150,000 on gel filtration under native conditions. The sera of breast cancer patients with measurable burden of disease also contained hyaluronic acid-stimulating activity, which was not present in normal serum donors or in breast cancer patients without evidence of disease. The production of this stimulating activity may contribute to the development of the malignant phenotype by inducing hyaluronic acid-rich microenvironments that are permissive to tumor cell invasion and metastases.

¹ Supported by Grant PO1-CA44768 from the National Cancer Institute (NIH, DHHS); by intramural grants from the Research Evaluation and Allocation Committee of the School of Medicine, the Academic Senate, and the Fetal Treatment Program, Department of Surgery of the University of California, San Francisco; and by a HEDCO Foundation fellowship.

² To whom requests for reprints should be addressed, at The Department of Pathology, School of Medicine, University of California, San Francisco, CA 94143-0506.

Received 12/29/88. Revised 3/27/89. Accepted 3/31/89.

This article has been cited by other articles:

				R. Stern Devising a pathway for hyaluronan catabolism: are we there yet? Glycobiology, December 1, 2003; 13(12): 105R - 115R. [Abstract] [Full Text] [PDF]